Oncobox believes that many late-stage cancer patients are dying prematurely because doctors lack a data-driven tool to help them decide which drugs currently on the market would most effectively fight individual patients’ specific cancers. That’s where Oncobox comes in. Oncobox is low-cost personalized genetic profiling to help doctors decide which drug to use. In a recent study conducted by leading cancer researchers in Europe and Asia on 900 patients with various late-stage cancers, Oncobox increased the effectiveness of targeted therapies from 25% to 64%. How does Oncobox work? Over 150 targeted cancer drugs are currently on the market. But deciding which of these drugs to give to late-stage cancer patients is not a simple task. Cancer doctors are in a race against the clock. They don’t always know which medication will be most effective for their patients. Because these drugs are expensive and typically have significant side effects, they can’t just try them all. Because of these barriers, targeted cancer therapies are effective only 25% of the time, and 70% of patients with late-stage cancers die due to the toxic side effects of ineffective drugs. Oncobox Dx analyses tumor DNA, RNA, and molecular pathways using algorithms to distinguish which molecular targets are the most crucial for individual cases. Doctors receive a clinically actionable report that shows them which drugs are likely to be most effective on the patient. We actively seek partners from pharma, hospitals/clinicians, payers, and genomic centers. Feel free to contact us at [email protected]. Our team and the scientific advisory board consisting of leading scientists and researchers from UCLA, Stanford, Johns Hopkins University, Boston University, Tufts University, and Rutgers University.
Oncobox offers a revolutionary approach to cancer treatment through deep molecular profiling of tumors. By evaluating the effectiveness of 170 novel targeted and immunotherapy drugs, Oncobox Dx assists healthcare providers in crafting highly effective, personalized treatment plans.
Oncobox offers tailored pricing based on the specific needs of each patient and healthcare provider. For detailed pricing information, please consult with an oncologist at one of our affiliated clinics.
Oncobox is driven by a dedicated team of experts in system biology, omics technologies, and clinical research. Our mission is to revolutionize precision oncology and improve patient outcomes through innovative diagnostics and personalized treatment strategies. Join us in pushing the boundaries of cancer care and research. Reach out to collaborate and make a difference in the fight against cancer.
Pioneering Breast Cancer Diagnostics for a Healthier Tomorrow
Personalized drug discovery for blood cancer.
Adventris makes cancer vaccines
AI-supported M&A Intelligence for BioPharma
Patient-derived 3D tissue reconstruction models for preclinical…
AI platform accelerating therapies for rare & inflammatory diseases.
Cofactor closes the precision medicine gap with predictive diagnostics
Kernal is creating mRNA 2.0 therapies that work in specific cells
A platform to make artificial viruses as cancer therapeutics.
Powerful cancer drugs that starve tumors
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS